FDA issues safety alert on breast implant-associated cancers
The Food and Drug Administration yesterday alerted health care providers and the public to reports of squamous cell carcinoma in scar tissue around breast implants, as well as lymphomas different than those previously associated with breast implants. The agency recommends that health care providers continue to report cancers around breast implants to help it identify and better understand this emerging issue.
Related News Articles
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., April 16 shared with attendees of AHA’s 2024 Annual Membership Meeting how her team is…
Headline
The White House April 16 released a strategy to guide the federal government in protecting the nation from infectious disease threats by working with other…
Blog
Since 2018, Black Maternal Health Week has been a national observance from April 11–17. This annual observance was created by the Black Mamas Matter Alliance…
Headline
Women with health-related social needs such as food insecurity, housing instability and lack of transportation were less likely to report receiving a mammogram…
Headline
For future public health emergencies, the Centers for Medicare & Medicaid Services should improve how it sets Medicare rates for clinical diagnostic…
Headline
The Office of Management and Budget March 28 released its final updated standards for Federal agencies on maintaining, collecting and presenting data on race…